Skip to main content

A Dose Optimization Study of MDMA-Assisted Therapy for PTSD in U.S. Veterans

This open label, within-subjects dose optimization trial will investigate the optimal number of MDMA-Assisted Therapy treatment cycles (i.e., one MDMA session and three integration sessions) in a sample of U.S. veterans with PTSD. Participants will complete from one to five cycles of MDMA-AT.

Status
recruiting
Phase
Phase 2
Institution
Bronx VA Medical Center
Principal investigator
Rachel Yehuda, PhD
Start date
2025-06-03
End date
2029-10-01
Registry ID
NCT06418178

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.